Differential prognostic impact of comorbidity in head and neck cancer

Head and Neck

Volumn 29, Issue 10, 2007, Pages 913-918

  Alho, Olli Pekka ^a   Hannula, Kalle ^a   Luokkala, Antti ^a   Teppo, Heikki ^a   Koivunen, Petri ^a   Kantola, Saara ^a  

^a UNIVERSITY OF OULU   (Finland)

Author keywords

Carcinoma; Comorbidity; Effect size; Head and neck; Survival

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CANCER MORTALITY; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CHARLSON SCORE; COHORT ANALYSIS; COMORBIDITY; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; LARYNX CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; SCORING SYSTEM; TONGUE CARCINOMA; TUMOR LOCALIZATION; HEAD AND NECK TUMOR; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY;

AGE FACTORS; AGED; COHORT STUDIES; COMORBIDITY; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT;

EID: 38449110225     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.20608     Document Type: Article

References (25)

1. Vokes EE, Weichselbaum RR, Lippman SM, Hong WK. Head and neck cancer. N Engl J Med 1993;328:184-194.
2. Piccirillo J. Inclusion of comorbidity in a staging system for head and neck cancer. Oncology 1995;9:831-836.
3. Piccirillo JF, Feinstein AR. Clinical symptoms and comorbidity: significance for the prognostic classification of cancer. Cancer 1996;77:834-842.
4. Read WL, Tierney RM, Page NC, et al. Differential prognostic impact of comorbidity. J Clin Oncol 2004;22:3099-3103.
5. Singh B, Bhaya M, Stern J, et al. Validation of the Charlson comorbidity index in patients with head and neck cancer: a multi-institutional study. Laryngoscope 1997;107:1469-1475.
6. Sabin SL, Rosenfeld RM, Sundaram K, Har-El G, Lucente FE. The impact of comorbidity and age on survival with laryngeal cancer. Ear Nose Throat J 1999;78:578,581-578,584.
7. Piccirillo JF. Importance of comorbidity in head and neck cancer. Laryngoscope 2000;110:593-602.
8. Ribeiro KC, Kowalski LP, Latorre MR. Impact of comorbidity, symptoms, and patients' characteristics on the prognosis of oral carcinomas. Arch Otolaryngol Head Neck Surg 2000;126:1079-1085.
9. Reid BC, Alberg AJ, Klassen AC, et al. Comorbidity and survival of elderly head and neck carcinoma patients. Cancer 2001;92:2109-2116.
10. Chen AY, Matson LK, Roberts D, Goepfert H. The significance of comorbidity in advanced laryngeal cancer. Head Neck 2001;23:566-572.
11. Hall SF, Rochon PA, Streiner DL, Paszat LF, Groome PA, Rohland SL. Measuring comorbidity in patients with head and neck cancer. Laryngoscope 2002;112:1988-1996.
12. Paleri V, Wight RG, Davies GR. Impact of comorbidity on the outcome of laryngeal squamous cancer. Head Neck 2003;25:1019-1026.
13. Pugliano FA, Piccirillo JF, Zequeira MR, et al. Clinical-severity staging system for oropharyngeal cancer: five-year survival rates. Arch Otolaryngol Head Neck Surg 1997;123:1118-1124.
14. Alho OP, Teppo H, Mäntyselkä P, Kantola S. Head and neck cancer in primary care: presenting symptoms and the effect of delayed diagnosis of cancer cases. CMAJ 2006;174:779-784.
15. Teppo L, Pukkala E, Lehtonen M. Data quality and quality control of a population-based cancer registry. Experience in Finland. Acta Oncol 1994;33:365-369.
16. International Union Against Cancer. TNM classification of malignant tumours, 4th ed. Berlin: Springer-Verlag; 1987.
17. Recommendations for the 1980 censuses of population and housing: the ECE region. Statistical standards and studies. New York: United Nations; 1978.
18. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-383.
19. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481.
20. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966;50:163-170.
21. Cox DR. Regression models and life-tables (with discussion). J R Stat Soc 1972;34:187-220.
22. Piccirillo JF, Costas I. The impact of comorbidity on outcomes. ORL J Otorhinolaryngol Relat Spec 2004;66:180-185.
23. Kaplan MH, Feinstein AR. The importance of classifying initial co-morbidity in evaluating the outcome of diabetes mellitus. J Chronic Dis 1974;27:387-404.
24. Piccirillo JF, Spitznagel EL Jr, Vermani N, Costas I, Schnitzler M. Comparison of comorbidity indices for patients with head and neck cancer. Med Care 2004;42:482-486.
25. Singh B, Bhaya M, Zimbler M, et al. Impact of comorbidity on outcome of young patients with head and neck squamous cell carcinoma. Head Neck 1998;20:1-7.